FDA 执法报告 D-0716-2026:Rohto-Mentholatum(越南)因无菌保证不足召回滴眼液
FDA drug enforcement D-0716-2026: Rohto-Mentholatum (Vietnam) Co., Ltd. — Lack of Assurance of Sterility
openFDA 执法报告 D-0716-2026 显示,Rohto-Mentholatum(越南)因无菌保证不足(Lack of Assurance of Sterility)自愿召回在美国全国分销的 Rohto Cooling Eye Drops Max Strength 滴眼液,分类为 Class II。
记录列出本次召回的分级、批次效期范围与美国全国分销情况,可用于核对无菌保证缺陷的召回边界。
FDA 药品召回执法报告 — D-0716-2026
报告发布日期:2026-07-29。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所表示的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "No. 16 Vsip, Street No. 5",
"address_2": "Vietnam Singapore Industrial Park",
"center_classification_date": "20260723",
"city": "Ho Chi Minh",
"classification": "Class II",
"code_info": "Lot #: 3H2V, 3H3V, Exp. Date 2026/07; 3J1V, 3J3V, 3J4V, 3J5V, Exp. Date 2026/09; 3K1V, 3K2V, Exp. Date 2026/10; 4A2V, Exp. Date 2026/12; 4B1V, 4B2V, 4B3V, Exp. Date 2027/01; 4F1V, 4F2V, 4F2V, 4F3V, 4F4V, Exp. Date 2027/05; 4G2V, 4G3V, 4G4V, 4G5V, Exp. Date 2027/06; 4H1V, Exp. Date 2027/07; 4I1V, 4I2V, 4I4V, 4I5V, Exp. Date 2027/08.",
"country": "Vietnam",
"distribution_pattern": "Nationwide within the United States",
"event_id": "99440",
"initial_firm_notification": "Letter",
"openfda": {},
"postal_code": "N/A",
"product_description": "Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011012, NDC 10742-8158-1",
"product_quantity": "6076306 cartons",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility",
"recall_initiation_date": "20260714",
"recall_number": "D-0716-2026",
"recalling_firm": "Rohto-Mentholatum (Vietnam) Co., Ltd.",
"report_date": "20260729",
"state": "N/A",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov